Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTUNG.L Regulatory News (TUNG)

  • There is currently no data for TUNG

Director/PDMR Shareholding

23 Oct 2013 13:10

RNS Number : 2195R
Tungsten Corporation PLC
23 October 2013
 



23 October 2013

 

Tungsten Corporation plc

Purchase of Shares by a Director

 

Tungsten Corporation plc (the "Company") has today been notified that on 22 October 2013 a director of the Company, Michael Spencer (through IPGL Limited, a private holding company controlled by Michael Spencer and his family interests) acquired 200,000 ordinary shares in the Company at a price of 231 pence per share.

 

Following this acquisition, Mr Spencer (through IPGL Limited) is interested in 980,485 ordinary shares in the Company representing 0.98 per cent. of the Company's issued share capital

 

 

Enquiries:

 

Tungsten Corporation plc

Jeffrey Belkin

 

 

Tel: 020 3435 5680

Charles Stanley Securities (Nomad and joint broker)

Marc Milmo / Dugald Carlean

 

Tel: 020 7149 6000

Canaccord Genuity Limited (Financial Adviser and joint broker)

Simon Bridges / Peter Stewart / Cameron Duncan

 

Tel: 020 7523 8000

 

Equus Group (Communications)

Piers Hooper / Sam Barton

 

 

Tel: 020 7223 1100

 

.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFEUFEDFDSESS
Date   Source Headline
15th Dec 20212:41 pmRNSStatement Re Possible Offer for Tungsten Corp
15th Dec 20212:35 pmEQSForm 8.3 - Maitland Institutional Services Limited: Form 8.3 (OPD) - Tungsten Corp Plc
15th Dec 20212:12 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Tungsten Corporation plc
15th Dec 20212:00 pmRNSForm 8.3 - Tungsten
15th Dec 20211:45 pmRNSForm 8.3
15th Dec 202112:13 pmBUSForm 8.3 - Tungsten Corporation plc
14th Dec 20215:35 pmRNSStatement re Possible Offer
14th Dec 20213:18 pmRNSStatement re Possible Offer
13th Dec 20217:01 amRNSInterim Results
13th Dec 20217:00 amRNSUS Litigation Settlement
7th Dec 20217:00 amRNSInvestor Presentation
3rd Dec 20217:00 amRNSPartnership Agreement
1st Dec 202111:27 amRNSHolding(s) in Company
30th Nov 202111:15 amRNSHolding(s) in Company
29th Nov 20214:41 pmRNSSecond Price Monitoring Extn
29th Nov 20214:36 pmRNSPrice Monitoring Extension
29th Nov 20217:00 amRNSHolding(s) in Company
25th Nov 20217:00 amRNSHolding(s) in Company
23rd Nov 20213:02 pmRNSHolding(s) in Company
22nd Nov 20215:44 pmRNSHolding(s) in Company
22nd Nov 20217:00 amRNSHolding(s) in Company
4th Nov 20214:36 pmRNSPrice Monitoring Extension
4th Nov 20217:00 amRNSCustomer Win
2nd Nov 20217:10 amRNSCustomer Contract Cancellation
15th Oct 20213:28 pmRNSResult of AGM
14th Oct 20214:36 pmRNSHolding(s) in Company
8th Oct 20214:41 pmRNSSecond Price Monitoring Extn
8th Oct 20214:36 pmRNSPrice Monitoring Extension
7th Oct 20214:41 pmRNSSecond Price Monitoring Extn
7th Oct 20214:36 pmRNSPrice Monitoring Extension
30th Sep 20217:07 amRNSISAE 3402 Accreditation
23rd Sep 20217:00 amRNSPosting of Report and Accounts and Notice of AGM
16th Sep 20215:03 pmRNSDirector Appointment
16th Sep 20218:40 amRNSSupply Chain Finance Partnership
27th Aug 20217:00 amRNSAdditional Listing and Total Voting Rights
23rd Aug 20217:00 amRNSDirector/PDMR Shareholdings
30th Jul 20217:00 amRNSFinal Results
15th Jun 20214:40 pmRNSSecond Price Monitoring Extn
15th Jun 20214:35 pmRNSPrice Monitoring Extension
14th Jun 20217:00 amRNSDirectorate Change
10th Jun 20214:40 pmRNSSecond Price Monitoring Extn
10th Jun 20214:35 pmRNSPrice Monitoring Extension
9th Jun 20217:00 amRNSChange of Chief Executive Officer
7th Jun 20217:00 amRNSCustomer Win
4th Jun 20217:00 amRNSTrading Update
20th May 20217:00 amRNSAppointment of Chief Financial Officer
20th Apr 20214:41 pmRNSSecond Price Monitoring Extn
20th Apr 20214:35 pmRNSPrice Monitoring Extension
13th Apr 20217:00 amRNSCustomer Win
30th Mar 202112:15 pmRNSAdditional Listing and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.